Dimenhydrinate Tablets — Medical Description

Dimenhydrinate is an H1-antihistamine and antiemetic medication primarily used to prevent and treat motion sickness, including associated nausea, vomiting, and dizziness. It acts centrally on the vestibular system and helps reduce the abnormal signals responsible for motion-induced nausea and vertigo.

Active Ingredient

Dimenhydrinate 50 mg per tablet — a commonly marketed tablet strength.
Therapeutic classification: Antihistamine / antiemetic
Route: Oral

Therapeutic Uses

Dimenhydrinate tablets are primarily indicated for:

Prevention and treatment of motion sickness
Relief of motion-sickness-associated nausea
Relief of vomiting
Relief of dizziness associated with motion sickness

Dimenhydrinate may also be used in some clinical settings for vertigo and inner-ear disorders, including symptoms associated with Ménière's disease; however, these uses should be based on medical assessment and the applicable local product authorization.

How Does Dimenhydrinate Work?

Dimenhydrinate is an antihistamine that acts on pathways involved in the body's balance and vestibular system. It reduces abnormal vestibular stimulation and thereby helps prevent the nausea, vomiting, and dizziness associated with motion sickness. Because it penetrates the central nervous system, drowsiness and sedation are important potential effects.

Recommended Administration

For prevention of motion sickness, dimenhydrinate is most effective when taken before exposure to the motion stimulus, rather than waiting until significant symptoms have developed. The CDC recommends taking oral motion-sickness medication sufficiently early to allow absorption.

For commonly marketed 50 mg tablets, U.S. OTC labeling states:

Age	Typical labeled dose
Adults & ≥12 years	50–100 mg every 4–6 hours; maximum 400 mg/24 hours
6 to <12 years	25–50 mg every 6–8 hours; maximum 150 mg/24 hours
2 to <6 years	25 mg every 6–8 hours; maximum 75 mg/24 hours
Under 2 years	Do not use unless specifically directed by a physician

For prevention, the first dose is generally taken 30–60 minutes before travel or the beginning of motion exposure.

Always follow the specific product's package leaflet or physician's instructions, as available strengths, age recommendations, and dosing instructions can vary between countries and formulations.

Common Side Effects

The most important adverse effect is drowsiness/sedation. Other possible effects include:

Drowsiness
Dizziness
Dry mouth
Blurred vision
Headache
Gastrointestinal discomfort
Difficulty urinating, particularly in susceptible patients

The CDC identifies drowsiness or sedation as the most common adverse effect associated with medications used for motion sickness.

Important Warnings & Precautions

Patients should consult a healthcare professional before using dimenhydrinate if they have:

Glaucoma
Chronic respiratory disease, including emphysema or chronic bronchitis
Difficulty urinating or prostatic enlargement
Other conditions that may be worsened by antihistamine effects

Do not give to children under 2 years of age unless specifically directed by a physician.

Driving & Alcohol

Dimenhydrinate may cause significant drowsiness and impaired alertness.

Patients should:

Avoid driving or operating machinery until they know how the medicine affects them.
Avoid alcoholic beverages while taking dimenhydrinate.
Avoid combining it with sedatives, tranquilizers, or other medicines that cause drowsiness unless advised by a healthcare professional, because sedation may be increased.

Pregnancy & Breastfeeding

Pregnant or breastfeeding patients should consult a healthcare professional before using dimenhydrinate to determine whether treatment is appropriate for their individual circumstances.

Overdose

Taking excessive amounts of dimenhydrinate can be dangerous. Overdose may produce serious central nervous system and cardiovascular effects. Accidental or intentional overdose requires urgent medical assessment.

Storage

Store according to the manufacturer's instructions. A commonly marketed 50 mg tablet product is labeled for storage at approximately 15–30°C and protection from excessive moisture. Always follow the storage conditions stated on the specific product packaging.

Patient Disclaimer

This information is intended for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Dimenhydrinate should be used according to the product's approved labeling or as directed by a qualified healthcare professional. Do not exceed the recommended dose. Dimenhydrinate may cause significant drowsiness; avoid alcohol and use caution with driving or operating machinery. Parents and caregivers should consult a healthcare professional before administering dimenhydrinate to young children, particularly children under 2 years of age. If severe symptoms, an allergic reaction, or suspected overdose occurs, seek immediate medical attention.

References

U.S. National Library of Medicine — MedlinePlus: Dimenhydrinate
U.S. CDC — Yellow Book 2026: Motion Sickness
U.S. National Library of Medicine — DailyMed: Dimenhydrinate 50 mg Tablets
U.S. National Library of Medicine — MedlinePlus Medical Encyclopedia: Dimenhydrinate Overdose